Blood | American Society of Hematology

Skip Nav Destination

Xiaosu Zhou; Xue Chen; Jiaqi Chen; Lijun Wen; Zhanglin Zhang; Ya-Zhen Qin; Panxiang Cao; Haizhou Xing; Yingchang Mi; Wei Wang; Guangsen Zhang; Ji Li; Huanling Wu; Zhifen Zhang; Jian Zhang; Zhan Su; Fang Wang; Yang Zhang; Xiaoli Ma; Jiancheng Fang; Ping Wu; Tong Wang; Gaowei Fan; Yang Zhao; David Jin; Xian Zhang; Xiujuan Ma; Qisheng Wu; Zhihua Zhang; Linya Wang; Futian Ma; Xia Xiao; Chengye Wu; Kai Sun; Ruijie Tang; Yun Zhang; Sanyun Wu; Ran Gao; Leping Zhang; Huyong Zheng; Yanli Zhao; Hong-Hu Zhu; Daopei Lu; Peihua Lu; Suning Chen; Hongxing Liu

Elsa Bernard; Robert P. Hasserjian; Peter L. Greenberg; Juan E. Arango Ossa; Maria Creignou; Heinz Tuechler; Jesus Gutierrez-Abril; Dylan Domenico; Juan S. Medina-Martinez; Max Levine; Konstantinos Liosis; Noushin Farnoud; Maria Sirenko; Martin Jädersten; Ulrich Germing; Guillermo Sanz; Arjan A. van de Loosdrecht; Yasuhito Nannya; Olivier Kosmider; Matilde Y. Follo; Felicitas Thol; Lurdes Zamora; Ronald F. Pinheiro; Andrea Pellagatti; Harold K. Elias; Detlef Haase; Christina Ganster; Lionel Ades; Magnus Tobiasson; Laura Palomo; Matteo Giovanni Della Porta; Pierre Fenaux; Monika Belickova; Michael R. Savona; Virginia M. Klimek; Fabio P. S. Santos; Jacqueline Boultwood; Ioannis Kotsianidis; Valeria Santini; Francesc Solé; Uwe Platzbecker; Michael Heuser; Peter Valent; Carlo Finelli; Maria Teresa Voso; Lee-Yung Shih; Michaela Fontenay; Joop H. Jansen; José Cervera; Norbert Gattermann; Benjamin L. Ebert; Rafael Bejar; Luca Malcovati; Seishi Ogawa; Mario Cazzola; Eva Hellström-Lindberg; Elli Papaemmanuil

Issue Highlights

Featured Content

Using NGS to refine risk stratification in T-ALL; a novel gene therapy approach in severe α-thalassemia; molecular taxonomy of MDS

NGS-based stratification refines the risk stratification in T-ALL and identifies a very-high-risk subgroup of patients

Use of HSC-targeted LNP to generate a mouse model of lethal α-thalassemia and treatment via lentiviral gene therapy

Molecular taxonomy of myelodysplastic syndromes and its clinical implications

Optimizing drug combinations for T-PLL: restoring DNA damage and P53-mediated apoptotic responses

Mitigation of checkpoint inhibitor–induced autoimmune hemolytic anemia through modulation of purinergic signaling

ASH Publications

American Society of Hematology